Returns | 1W : -0.3% , 1M : 6.9%,1Y : 58.1% |
LT :   |
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : High |
ST :   |
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward Pledged Shares : Average [>25% and <50%] |
Peers & Returns | 1W | 1M | 1Y |
APOLLO HOSPITALS ENTERPRISE LTD | -0.3% | 6.9% | 58.1% |
DR LAL PATHLABS LTD | 2.9% | 3.2% | 44% |
FORTIS HEALTHCARE LTD | 1.2% | 7.5% | 8.1% |
METROPOLIS HEALTHCARE LTD | -0% | 12.1% | 35.6% |
ASTER DM HEALTHCARE LTD | 0.4% | -5.5% | -1.7% |
NARAYANA HRUDAYALAYA LTD | 1.9% | 7.6% | 32% |
THYROCARE TECHNOLOGIES LTD | -2.9% | -0.9% | 67.5% |
SHALBY LTD | -2.9% | 3.6% | 11.3% |
KOVAI MEDICAL CENTER & HOSPITAL LTD | -3.5% | 7.5% | 62.3% |
Ratio | Value |
---|---|
P/E P/B P/S |
79.55
P/E Calculated based on EPS of 32.68
[ Mar2020 - Consolidated Results ] 10.87
P/B Calculated based on Book Value of 239.1
[ Mar2020 - Consolidated Results ] 3.33
P/S Calculated based on Revenues of 10846.4 Cr
[ TTM - Consolidated Results ] |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
41% 32% 42% |
Pledged Shares |
33.65 % |
---|---|
As on : Sep2020 | |
If less than 25% | Good |
If between 25% and 50% | Neutral |
If greater than 50% | Bad |